Paradise Ultrasound Renal Denervation System for HTN
Patients with resistant hypertension struggle to reduce blood pressure. The Paradise Ultrasound RDN System offers a high standard for lowering blood pressure.
recormedical.comCrawled Nov 21, 2026
Patients with resistant hypertension struggle to reduce blood pressure. The Paradise Ultrasound RDN System offers a high standard for lowering blood pressure.
The Paradise uRDN System demonstrates blood pressure reduction in clinical results.
CMS issued a NCD for renal denervation therapy, including Recor Medical's Paradise Ultrasound RDN System for uncontrolled hypertension.
2025 AHA/ACC guideline recognizes Renal Denervation as an adjunct therapy for appropriately selected patients with uncontrolled or resistant hypertension.
The Paradise Ultrasound Renal Denervation System is a therapy option for lowering patients' blood pressure.
Centers for Medicare & Medicaid Services approved Transitional Pass-through (TPT) payment for Paradise Ultrasound Renal Denervation for outpatient procedures.
Renal denervation is a therapy option for lowering patients' blood pressure.
Publications feature the Paradise Ultrasound RDN System and clinical evidence on renal denervation procedures.
The page presents clinical evidence, expert videos, case studies, and insights on the Paradise Ultrasound Renal Denervation system for treating uncontrolled blood pressure.
The American Medical Association created two CPT codes for renal denervation procedures, effective January 1, 2028.
Recor Medical and Otsuka Medical Devices appointed Helen Reeve-Stoffer as President and CEO to lead development of the Paradise Ultrasound Renal Denervation system.
Recor Medical, Inc. (“Recor”), a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., today announced that the Paradise Ultrasound Renal Denervation (uRDN) system has been recognized with a TAG award in the Medical Devices: Cardiovascular Therapeutic Innovation category.
Recor Medical advances ultrasound technology for hypertension management.
Recor Medical, part of Otsuka Medical Devices, was founded in 2009 with a singular focus: create a breakthrough therapy to help treat hypertension.
Recor Medical, Inc. is committed to conducting its business by the highest ethical and compliance standards.
This webpage serves as notice under 35 U.S.C. §287(a) that the following products are protected by one or more U.S. patents.
Paradise Ultrasound Renal Denervation (RDN) procedure treats hypertension by calming the overactive renal nerves. Risks include pain & vascular complications